Exascale Labs Holdings Inc. (XLAB)
NASDAQ: XLAB · Real-Time Price · USD
4.485
+0.095 (2.16%)
At close: Sep 8, 2026, 4:00 PM EDT
4.400
+0.010 (0.23%)
Pre-market: Sep 9, 2026, 6:33 AM EDT

Exascale Labs Holdings Balance Sheet

Millions USD. Fiscal year is Jul - Jun.

Assets

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Mar '26 Jun '25 Jun '24
Cash & Equivalents
0.984.230.97
Cash & Short-Term Investments
0.984.230.97
Cash Growth
-336.43%-
Receivables
1.830.150.12
Other Current Assets
5.322.923.28
Total Current Assets
8.137.34.37
Property, Plant & Equipment
0.010.020.02
Total Assets
8.247.324.39

Liabilities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Mar '26 Jun '25 Jun '24
Accounts Payable
0.740.090.13
Current Unearned Revenue
0.110.430.1
Other Current Liabilities
28.319.89.66
Total Current Liabilities
29.1520.329.88
Total Liabilities
29.1520.329.88

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Mar '26 Jun '25 Jun '24
Common Stock
000
Additional Paid-In Capital
0.220.220.07
Comprehensive Income & Other
--13.22-5.56
Shareholders' Equity
-20.91-13-5.49
Total Liabilities & Equity
8.247.324.39

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Mar '26 Jun '25 Jun '24
Net Cash (Debt)
0.984.230.97
Net Cash Growth
-336.43%-
Working Capital
-21.02-13.02-5.51
Tangible Book Value
-20.91-13-5.49
Machinery
0.030.030.03
SEC Filings: 10-K · 10-Q